TL;DR
This paper reveals a novel negative feedback loop in bacteria where the second messenger c-di-GMP directly inhibits the protein deacetylase CobB. This inhibition, in turn, affects acetyl-CoA metabolism and the activity of YdeH, a key enzyme in c-di-GMP production, highlighting a sophisticated regulatory mechanism.
What Problem Does This Paper Address?
Bacteria utilize cyclic diguanosine monophosphate (c-di-GMP) as a crucial second messenger to regulate a wide array of cellular processes, including motility, biofilm formation, and virulence. However, the precise mechanisms by which c-di-GMP levels are controlled and how it interacts with other cellular components are still being uncovered. CobB, a well-known deacetylase, plays roles in energy metabolism and other functions, but its direct connection to c-di-GMP signaling was unclear. This study aims to elucidate how c-di-GMP interacts with CobB and to understand the functional consequences of this interaction, particularly in the context of c-di-GMP production and its downstream effects.
Methods
The researchers employed a multi-pronged approach:
- E. coli Proteome Microarray: This high-throughput technique was used to screen for proteins that bind to c-di-GMP, identifying CobB as a strong binder.
- Biochemical Assays:
- Streptavidin Blotting: Used to validate the binding of c-di-GMP to CobB.
- Isothermal Titration Calorimetry (ITC) and Microscale Thermophoresis (MST): These methods were used to quantify the binding affinity (Kd) between c-di-GMP and CobB.
- Deacetylation Assays: Assessed CobB's activity on known substrates (Acs, CheY, NhoA) in the presence and absence of c-di-GMP to determine if c-di-GMP inhibits CobB's deacetylase function.
- Enzyme Kinetics: Measured the catalytic rate of CobB deacetylation in the presence of varying c-di-GMP concentrations to characterize the inhibition mechanism.
- Mutagenesis Studies: Specific residues in CobB (R8, R17, E21) were mutated to alanine to identify those critical for c-di-GMP binding.
- In Vivo Studies:
- E. coli Strains: Utilized strains with altered c-di-GMP levels (overexpressing YdeH or a dysfunctional YdeH mutant) and CobB-deficient strains to study the effects of c-di-GMP on CobB activity and vice versa.
- Growth Curve Analysis: Monitored bacterial growth under different conditions to assess the physiological impact of the observed molecular interactions.
- Stable Isotope Labeling with Amino acids in Cell culture (SILAC) coupled with Mass Spectrometry (MS): Used to quantitatively compare protein acetylation levels in different E. coli strains, revealing global effects of c-di-GMP on CobB-dependent deacetylation.
- Mass Spectrometry (MS): Employed for in-depth analysis of acetylation sites on YdeH and to identify sites deacetylated by CobB.
- Structural Analysis: Investigated the potential structural impact of acetylation on YdeH.
Datasets
- E. coli Proteome Microarray Data: Raw data published in the Protein Microarray Database (www.proteinarray.cn) with accession number PMDE271.
- SILAC MS Proteomics Raw Data: Deposited to the ProteomeXchange Consortium via the PRIDE partner repository with dataset identifier PXD007616.
- Mass Spectrometry Raw Data for Deacetylation Site Identification: Submitted to PRIDE with project accession PXD008113.
Key Insights and Ideas
- c-di-GMP Directly Binds and Inhibits CobB: This is a significant finding, establishing a direct molecular link between the second messenger and a key deacetylase. The binding is specific, with c-di-GMP showing much stronger affinity than cGMP or c-di-AMP.
- A Novel Negative Feedback Loop: The paper proposes a sophisticated regulatory circuit: c-di-GMP binds to CobB, inhibiting its activity. CobB normally deacetylates YdeH, a c-di-GMP producing enzyme. By inhibiting CobB, c-di-GMP indirectly leads to increased YdeH activity and thus more c-di-GMP production, creating a feedback loop.
- CobB's Role in YdeH Stability and Activity: CobB deacetylation of YdeH at lysine 4 (K4) is crucial for YdeH's stability and its diguanylate cyclase (DGC) activity. Acetylation of YdeH appears to lead to aggregation and reduced solubility.
- Metabolic Implications: The inhibition of CobB by c-di-GMP affects acetyl-CoA levels, a central component of energy metabolism. This suggests c-di-GMP can influence bacterial energy status through this regulatory axis.
- Conserved Mechanism: The binding and inhibitory effects of c-di-GMP on CobB appear to be conserved across various prokaryotes, suggesting a fundamental regulatory mechanism.
Key Results
- c-di-GMP binds to CobB with a Kd of 21.6 µM (ITC) and 22.7 ± 1.63 µM (MST).
- c-di-GMP noncompetitively inhibits CobB's deacetylase activity with a Ki of 32.27 µM.
- Residues R8, R17, and E21 in CobB's N-terminal domain are essential for c-di-GMP binding but not for catalytic activity.
- CobB effectively deacetylates YdeH at K4, enhancing YdeH's stability and DGC activity.
- Overexpression of YdeH leads to a 36% increase in c-di-GMP levels in WT cells compared to CobB-deficient cells.
- SILAC-MS analysis revealed that c-di-GMP globally affects CobB-dependent deacetylation in vivo.
Limitations and Future Work
- In Vitro vs. In Vivo Affinity: The measured Kd values for c-di-GMP binding to CobB in vitro are higher than the typical micromolar concentrations of c-di-GMP observed in vivo. The authors suggest that this discrepancy might be due to unidentified molecular factors in vivo or the spatially uneven distribution of c-di-GMP within the crowded bacterial cytoplasm, where local concentrations could be much higher.
- Mechanism of YdeH Regulation: While the study identifies K4 as a critical site for YdeH acetylation and its impact on stability and activity, the precise structural mechanism by which acetylation affects YdeH's conformation and dimerization requires further detailed investigation.
- Broader Implications: The authors suggest that since CobB is conserved across prokaryotes and even has homologs in eukaryotes (sirtuins), c-di-GMP might also interact with human sirtuins, potentially playing roles in various biological processes, including host-pathogen interactions. This opens avenues for exploring c-di-GMP's influence beyond bacterial systems.
- Future Functional Studies: The established negative feedback loop provides a framework for future research into the intricate regulation of c-di-GMP levels and CobB-based protein acetylation.
Summary updated